MATN3 and cancer: The pan-cancer analysis unveiled a striking dichotomy in MATN3 expression, with consistent overexpression in numerous cancer types, including ACC, BLCA, BRCA, COAD, ESCA, GBM, LGG, HNSC, LIHC, PAAD, READ, STAD, and TGCT.